Anti-inflammatory properties of Type I interferons

被引：73

作者：

Billiau, Alfons ^{[1
]}

机构：

[1] Katholieke Univ Leuven, Rega Inst, BE-3000 Louvain, Belgium

来源：

ANTIVIRAL RESEARCH | 2006年 / 71卷 / 2-3期

关键词：

interferon; inflammation;

D O I：

10.1016/j.antiviral.2006.03.006

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The notion that Type I interferons (interferon-alpha and -beta) possess anti-inflammatory potential is supported by data from clinical application in multiple sclerosis, by studies on cultured immune-competent cells and by investigation of experimental diseases in whole animals. These observations deserve the attention of virologists for their potential role in the pathogenesis and clinical management of virus infections. (c) 2006 Elsevier B.V. All rights reserved.

引用

页码：108 / 116

页数：9

共 87 条

[1] SUPPRESSION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS BY INTERFERON [J].

ABREU, SL .

IMMUNOLOGICAL COMMUNICATIONS, 1982, 11 (01) :1-7

[2] INHIBITION OF PASSIVE LOCALIZED EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS BY INTERFERON [J].

ABREU, SL ;

TONDREAU, J ;

LEVINE, S ;

SOWINSKI, R .

INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1983, 72 (01) :30-33

[3] TYPE-I INTERFERONS (IFN-ALPHA AND IFN-BETA) SUPPRESS CYTOTOXIN (TUMOR-NECROSIS-FACTOR-ALPHA AND LYMPHOTOXIN)PRODUCTION BY MITOGEN-STIMULATED HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS [J].

ABUKHABAR, KS ;

ARMSTRONG, JA ;

HO, M .

JOURNAL OF LEUKOCYTE BIOLOGY, 1992, 52 (02) :165-172

[4] Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment [J].

Avolio, C ;

Filippi, M ;

Tortorella, C ;

Rocca, MA ;

Ruggieri, M ;

Agosta, F ;

Tomassini, V ;

Pozzilli, C ;

Stecchi, S ;

Giaquinto, P ;

Livrea, P ;

Trojano, M .

MULTIPLE SCLEROSIS, 2005, 11 (04) :441-446

[5] Human monocyte-derived dendritic cells produce bioactive gelatinase B:: Inhibition by IFN-ß [J].

Bartholomé, EJ ;

Van Aelst, I ;

Koyen, E ;

Kiss, R ;

Willems, F ;

Goldman, M ;

Opdenakker, G .

JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2001, 21 (07) :495-501

[6]

BILLIAU A, 1988, J IMMUNOL, V140, P1506

[7] CYTOKINES AND THEIR INTERACTIONS WITH OTHER INFLAMMATORY MEDIATORS IN THE PATHOGENESIS OF SEPSIS AND SEPTIC SHOCK [J].

BILLIAU, A ;

VANDEKERCKHOVE, F .

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1991, 21 (06) :559-573

[8] VLA-4 expression on peripheral blood lymphocytes is downregulated after treatment of multiple sclerosis with interferon beta [J].

Calabresi, PA ;

Pelfrey, CM ;

Tranquill, LR ;

Maloni, H ;

McFarland, HF .

NEUROLOGY, 1997, 49 (04) :1111-1116

[9] Increases in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon beta-1b [J].

Calabresi, PA ;

Tranquill, LR ;

Dambrosia, JM ;

Stone, LA ;

Maloni, H ;

Bash, CN ;

Frank, JA ;

McFarland, HF .

ANNALS OF NEUROLOGY, 1997, 41 (05) :669-674

[10] T lymphocytes conditioned with Interferon β induce membrane and soluble VCAM on human brain endothelial cells [J].

Calabresi, PA ;

Prat, A ;

Biernacki, K ;

Rollins, J ;

Antel, JP .

JOURNAL OF NEUROIMMUNOLOGY, 2001, 115 (1-2) :161-167

← 1 2 3 4 5 6 7 8 9 →